Geron
GERN
#6632
Rank
โ‚ฌ0.65 B
Marketcap
1,02ย โ‚ฌ
Share price
2.61%
Change (1 day)
-24.74%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -โ‚ฌ44.12 Million

According to Geron's latest financial reports the company's current earnings are โ‚ฌ0.18 Billion. , an increase over its 2024 earnings that were of -โ‚ฌ0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚ฌ43.78 Million-67.42%
2024 -โ‚ฌ0.14 Billion-11.23%
2023 -โ‚ฌ0.16 Billion30.22%
2022 -โ‚ฌ0.12 Billion20.15%
2021 -โ‚ฌ96.75 Million50.08%
2020 -โ‚ฌ64.47 Million4.46%
2019 -โ‚ฌ61.71 Million130.68%
2018 -โ‚ฌ26.76 Million8.84%
2017 -โ‚ฌ24.58 Million-3.08%
2016 -โ‚ฌ25.36 Million-22080.6%
2015 โ‚ฌ0.11 M-100.38%
2014 -โ‚ฌ30.64 Million-7.14%
2013 -โ‚ฌ33 Million
2011 -โ‚ฌ78.06 Million19.04%
2010 -โ‚ฌ65.58 Million8.45%
2009 -โ‚ฌ60.47 Million-2.51%
2008 -โ‚ฌ62.03 Million14.65%
2007 -โ‚ฌ54.1 Million32.68%
2006 -โ‚ฌ40.78 Million25.59%
2005 -โ‚ฌ32.47 Million4.36%
2004 -โ‚ฌ31.11 Million19.73%
2003 -โ‚ฌ25.99 Million-15.46%
2002 -โ‚ฌ30.74 Million1.94%
2001 -โ‚ฌ30.15 Million33.59%
2000 -โ‚ฌ22.57 Million27.53%
1999 -โ‚ฌ17.7 Million63.13%
1998 -โ‚ฌ10.85 Million15.6%
1997 -โ‚ฌ9.39 Million-10.66%
1996 -โ‚ฌ10.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚ฌ8.43 B-19,369.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚ฌ1.52 B-3,588.90%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚ฌ59.61 Million 36.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚ฌ0.10 B-342.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ8.17 Million-81.34%๐Ÿ‡บ๐Ÿ‡ธ USA